About
Tuygan Goker brings over 40 years of senior-level experience with F. Hoffman-La Roche, Ltd., to his role as a board member at Novimmune. Most recently, he was the Director of Emerging Markets at Roche, where he was responsible for updating the company's wordlwide strategy. Before that, he served as the Pharma Operational Head and Chairman of Roche's CEMAI Region, which included 110 countries in Central and Eastern Europe, the Middle East, Central Asia, Africa, and the Indian subcontinent. During his career, Tuygan was primarily focused on building the Roche pharmaceutical business in emerging market countries, particularly Brazil, Russia, India, China, South Korea, Mexico and Turkey. He was responsible for founding numerous affiliates, joint ventures and partnerships, as well as negotiating and finalizing multiple manufacturing and commercial deals. After his departure he established several pharma companies including TRPHARM & KONSINA focused on research and development, manufactu
Position in the VCSift Database
- • 7 investors hold the Founder, CEO and Chairman role in VCSift. Tuygan Goker is one of them.
- • 170 investors are based in Turkey.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Turkey
Contact Information
Find more investors like Tuygan
Search Investors